| Price | 115.60p on 20-03-2026 at 19:20:08 |
|---|---|
| Change | -1.60p -1.37% |
| Buy | 116.80p |
| Sell | 115.80p |
| Last Trade: | Buy 946.00 at 115.60p |
| Day's Volume: | 423,659 |
| Last Close: | 115.60p |
| Open: | 119.00p |
| ISIN: | GB00BY2Z0H74 |
| Day's Range | 115.60p - 119.00p |
| 52wk Range: | 100.40p - 148.00p |
| Market Capitalisation: | £279.53m |
| VWAP: | 116.21477p |
| Shares in Issue: | 241.81m |
PureTech (PRTC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 946 | 115.60p | Automatic Execution |
16:39:01 - 20-Mar-26 |
| Buy* | 1,662 | 115.60p | Automatic Execution |
16:39:01 - 20-Mar-26 |
| Buy* | 251,349 | 115.60p | Suspected BUY Trade |
16:35:18 - 20-Mar-26 |
| Buy* | 313 | 116.60p | Automatic Execution |
16:29:46 - 20-Mar-26 |
| Buy* | 353 | 116.60p | Automatic Execution |
16:29:46 - 20-Mar-26 |
| Buy* | 239 | 116.60p | Automatic Execution |
16:29:46 - 20-Mar-26 |
| Sell* | 239 | 116.20p | Automatic Execution |
16:29:34 - 20-Mar-26 |
| Buy* | 354 | 116.60p | Automatic Execution |
16:29:34 - 20-Mar-26 |
| Unknown* | 673 | 116.20p | OTC Trade |
16:29:25 - 20-Mar-26 |
| Buy* | 19 | 116.40p | Automatic Execution |
16:29:25 - 20-Mar-26 |
PureTech (PRTC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Mar 2026 4:35 pm | RNS | PDMR Notification RSU Vesting |
| 2nd Mar 2026 7:00 am | RNS | Total Voting Rights |
| 25th Feb 2026 7:00 am | RNS-R | PRTC to Present at Leerink Healthcare Conference |
| 19th Feb 2026 5:15 pm | RNS-R | PRTC's Deupirfenidone Granted FDA & EU ODD for IPF |
| 6th Jan 2026 12:00 pm | RNS-R | PureTech to Present at the JP Morgan Conference |
| 18th Dec 2025 7:00 am | RNS | PureTech Appoints Robert Lyne as CEO |
| 10th Dec 2025 5:41 pm | RNS | Results of AGM on June 16, 2025 – Update Statement |
| 10th Dec 2025 5:30 pm | RNS | Holding(s) in Company |
| 8th Dec 2025 7:00 am | RNS-R | PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26 |
| 5th Dec 2025 6:00 pm | RNS-R | PRTC's Gallop: Positive Initial Topline AML Data |
